Details for Patent: 10,828,310

✉ Email this page to a colleague

Which drugs does patent 10,828,310 protect, and when does it expire?

Patent 10,828,310 protects XARELTO and is included in one NDA.

Protection for XARELTO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 10,828,310

Title:	Reducing the risk of cardiovascular events
Abstract:	Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.
Inventor(s):	Bruns; Nancy Cook (Kassel, DE), Misselwitz; Frank (Heidelberg-Neuenheim, DE), Eikelboom; John William Andrew (Hamilton, CA), Connolly; Stuart J. (Hamilton, CA), Yusuf; Salim (Hamilton, CA)
Assignee:	BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)
Application Number:	16/264,032
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 10,828,310

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Janssen Pharms	XARELTO	rivaroxaban	TABLET;ORAL	022406-004	Oct 11, 2018		RX	Yes	No	⤷ Sign Up	⤷ Sign Up			Y		⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.